1. Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. (May 2015) Authors: Mustacchi, G; Puglisi, F; Molino, AM; Crivellari, D; Ghiotto, C; Ferro, A; Brunello, A; Saracchini, S; Turazza, M; Cretella, E; Iop, A; Malagoli, M; Stefani, M Journal: Future oncology Issue: Volume 11:Number 10(2015) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. (May 2015) Authors: Mustacchi, G; Puglisi, F; Molino, AM; Crivellari, D; Ghiotto, C; Ferro, A; Brunello, A; Saracchini, S; Turazza, M; Cretella, E; Iop, A; Malagoli, M; Stefani, M Journal: Future oncology Issue: Volume 11:Number 10(2015) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. (May 2015) Authors: Mustacchi, G; Puglisi, F; Molino, AM; Crivellari, D; Ghiotto, C; Ferro, A; Brunello, A; Saracchini, S; Turazza, M; Cretella, E; Iop, A; Malagoli, M; Stefani, M Journal: Future oncology Issue: Volume 11:Number 10(2015) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗